Rapid dissemination of SIV following oral inoculation

Jeffrey M Milush1, David Kosub, Marta Marthas

  • 1Department of Internal Medicine, University of Texas Southwestern Medical Center, 5323 Harry Hines Boulevard, Dallas, TX 75390-9113, USA.

AIDS (London, England)
|December 29, 2004
PubMed
Abstract

Insights

Oral inoculation of macaques with SIVmac251 shows rapid viral spread to lymph nodes within 1-2 days. The oral and esophageal mucosa, and tonsils are identified as initial sites of infection, highlighting challenges for vaccine development.

Area of Science:

  • Virology
  • Immunology
  • Primatology

Background:

  • Simian immunodeficiency virus (SIV) infection in macaques serves as a model for understanding human immunodeficiency virus (HIV) pathogenesis.
  • Oral mucosal transmission is a significant route for various viral infections, yet the early events of SIV oral transmission remain incompletely understood.

Purpose of the Study:

  • To investigate the initial sites of SIV transmission and subsequent dissemination following non-traumatic oral inoculation in a macaque model.
  • To characterize the temporal dynamics of viral spread in lymphoid and non-lymphoid tissues.

Main Methods:

  • Rhesus macaques (juvenile and neonate) were orally inoculated with SIVmac251.
  • Tissues were collected at multiple time points (1, 2, 4, 7, and 14 days post-inoculation) for analysis.
  • Molecular techniques, including in situ hybridization, were employed to detect SIV nucleic acid and identify infected cells.

Main Results:

  • SIV nucleic acid was detected in the oral mucosa, esophagus, and tonsils as early as 1 day post-exposure.
  • Rapid viral dissemination to regional and peripheral lymph nodes occurred by 1-2 days post-inoculation.
  • Viral load increased significantly by 7 days post-inoculation, with T cells and macrophages identified as key infected cell types.

Conclusions:

  • The oral and esophageal mucosa, along with tonsils, are identified as primary sites for SIV infection following oral exposure.
  • The rapid dissemination of SIV through the lymphatic system presents a significant challenge for developing effective vaccines, particularly those relying on an amnestic immune response.